Detection of extended spectrum beta lactamase in gram negative pathogenic bacteria
Size: 997.82 KB
Language: en
Added: Feb 16, 2022
Slides: 8 pages
Slide Content
ESBL Detection Dr. Samira Fattah PhD in Medical Bacteriology College of Health Sciences-HMU
ESBL Extended Spectrum Beta Lactamases (ESBL) are β-lactamases capable of conferring bacterial resistance to the penicillins; first-, second- and third-generation cephalosporins; and aztreonam (but not the cephamycins “like Cefoxitin” or carbapenems) by hydrolysis of these antibiotics, and which are inhibited by β-lactamase inhibitors such as clavulanic acid This can limit treatment options for ESBL-producing pathogens Early diagnosis followed by appropriate treatment is essential to decrease both mortality and morbidity rates of diseases caused by such pathogenic bacteria.
Confirmatory Tests for ESBL Production Double-disk synergy test Combined disk test ESBL E tests Automated method Polymerase chain reaction (PCR) – TEM, SHV, STX-M and OXA genes Sequencing
Double-disk synergy test Principle ESBL produce enzyme that destroy beta-lactam antibiotic. That enzyme is inhibited by acid clavulanic and restore the activity of the beta-lactam antibiotic. In the synergy test, what happened is that the clavulanic acid in Amoxicillin-clavulanic acid inhibit beta-lactamase and the Cephalosporin become active on the bacteria and the diameter of inhibition becomes wider.
Double-disk synergy test Requirements : Mueller-Hinton agar 0.5 McFarland standard. Ceftazidime CAZ disk (30 µg) or Cefpodoxime FEP (30 μ g) Cefotaxime CTX disk (30 µg) Amoxicillin-clavulanate disk (AMC, 20+10 µg) Incubator
Double-disk synergy test Method Prepare MHA Prepare 0.5 McFarland standard suspension of enterobacteriaceae isolates using direct colony suspension. Make a lawn culture of bacteria in agar plates paired discs of CAZ (30 µg) and CTX (30 µg) were each positioned at distances of 20 mm ( centre to centre ) from amoxicillin-clavulanate disc (AMC, 20+10 µg). Plates were read after overnight incubation at 35°C.
Double-disk synergy test Result and interpretation The test is considered as positive when a decreased susceptibility to cefotaxime is combined with a clear-cut enhancement of the inhibition zone of cefotaxime in front of the clavulanate-containing disk, often resulting in a characteristic shape-zone referred to as ‘champagne-cork’ or ‘keyhole’.
Double-disk synergy test for extended spectrum beta-lactamases in A. baumannii , A (positive result), B (negative result). AMC-Amoxycillin + Clavulanate, CTX-Cefotaxime, FEP-Cefepime (A clear extension of the edge (Synergy) of the FEP inhibition zone towards the disc containing clavulanate).